RxDoctor Payments DataLook up a doctor →

Marcelo Marin

Primary Care · Englewood, NJNPI 1730582800

Payments from drug & device makers

$16,579in general payments, 2019–2025

Across 1,142 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$3K
  • AbbVie$3K
  • Neurocrine Biosciences, Inc.$1K
  • MDD US Operations, LLC$1K
  • Lundbeck LLC$905
  • Pfizer$854
  • plus $7K from 43 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.292$3,123
AbbVie(2 entities)164$2,763
Neurocrine Biosciences, Inc.70$1,096
MDD US Operations, LLC61$1,071
Lundbeck LLC60$905
Pfizer76$854
EMD Serono, Inc.20$853
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC59$849
Acadia Pharmaceuticals Inc26$561
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)41$522
Takeda Pharmaceuticals U.S.A., Inc.41$517
SK Life Science, Inc.28$389
Otsuka America Pharmaceutical, Inc.24$356
Axsome Therapeutics, Inc.20$346
Kowa Pharmaceuticals America, Inc.16$225
Lilly USA, LLC15$218
Bristol Myers Squibb9$148
UCB, Inc.8$145
Novartis8$143
Biohaven Pharmaceutical Holding Company Ltd.16$138
Scilex Pharmaceuticals Inc.8$129
E.r. Squibb & Sons, L.L.C.1$122
Amgen6$104
Eisai Inc.7$97
Sunovion Pharmaceuticals Inc.10$82
Idorsia Pharmaceuticals US Inc5$77
Sumitomo Pharma America, Inc.6$76
Collegium Pharmaceutical, Inc.6$76
Cardiva Medical, Inc.4$58
Impel Pharmaceuticals Inc.3$49
Redhill Biopharma Inc.3$44
Biogen2$43
ANI Pharmaceuticals, Inc.2$37
TG Therapeutics, Inc.2$36
Vanda Pharmaceuticals Inc.2$33
Supernus Pharmaceuticals, Inc.2$31
Neurelis, Inc.2$29
Avanir Pharmaceuticals, Inc.2$29
Currax Pharmaceuticals LLC2$27
Adamas Pharmaceuticals, Inc.2$27
G Medical Diagnostic Services, Inc.2$25
Biohaven Pharmaceuticals, Inc.2$25
Azurity Pharmaceuticals, Inc.1$19
Johnson & Johnson1$15
Argenx US, Inc.1$14
Almatica Pharma LLC1$14
Acorda Therapeutics, Inc1$14
Biodelivery Sciences International, Inc.1$12
Forte Bio-pharma LLC1$11

How this compares

$16,579 in reported general payments places this provider in the 95th percentile of 330 primary care providers in New Jersey.

See all primary care providers in New Jersey →

Medicare billing

Part B allowed, 2024
$3,702
Medicare patients
19
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other primary care in Englewood

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →